Precision at the Heart of Pathology
Epredia (epredia.com) scores 79 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Manufacturing brands, Technology brands, in the 64th percentile of 9869 Healthcare brands.
Epredia is a healthcare technology company founded in 2019 and headquartered in Neuilly-sur-Seine, specializing in anatomical pathology equipment for cancer diagnostics. The company provides end-to-end solutions covering tissue processing, embedding, slide printing, and identification, aimed at improving workflow, efficiency, and diagnostic confidence in pathology laboratories. Its products and services target pathology labs, hospital diagnostic departments, and healthcare professionals involved in cancer diagnostics and tissue analysis worldwide.
| Brand Name | Epredia |
|---|---|
| Domain | epredia.com |
| Industry | Healthcare, Manufacturing |
| Founded | 2019 |
| Headquarters | Neuilly-sur-Seine |
| Main Competitors | Leica Biosystems (80/100), Thermo Fisher Scientific (90/100), Sakura Finetek, Roche Diagnostics (Ventana Medical Systems) (83/100), Agilent Technologies (79/100) |
Moz Domain Authority 30/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #4,209,849 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Anatomical pathology equipment for cancer diagnostics, helping laboratories improve workflow, efficiency, and diagnostic confidence. Explore Solutions." (Meta description: 16 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 3 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare.
Social footprint: verified profiles on LinkedIn, Facebook, YouTube, Instagram; no detected presence on X (Twitter), GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Epredia?", Claude could identify the brand as of September 2026. Epredia is a company specializing in cancer diagnostics and pathology solutions, providing instruments, reagents, software and consumables used in histology and anatomic pathology labs. It was formed from the combination of Thermo Fisher's Anatomical Pathology business and PHC Ho Best known for Anatomic pathology and histology lab equipment and consumables, including tissue processing and slide staining systems.
When asked "Best brands similar to Epredia?", Claude would recommend Epredia as of September 2026. It's a well-known name in pathology lab equipment and would naturally come up alongside brands like Leica Biosystems and Sakura Finetek when discussing histology solutions.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Epredia's main competitors in Healthcare: Leica Biosystems (80/100), Thermo Fisher Scientific (90/100), Roche Diagnostics (Ventana Medical Systems) (83/100), Agilent Technologies (79/100).
Sources: Brand Analyzer scan
Epredia has limited AI-search visibility, scoring 39/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 55, recommendation 54). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Epredia official site
Epredia was founded in 2019. Epredia operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Epredia is headquartered in Neuilly-sur-Seine. Epredia operates in the Healthcare category.
Sources: Wikidata
Epredia offers anatomical pathology equipment and consumables covering the full tissue diagnostic workflow, including tissue processing, tissue embedding, slide printing, and slide identification systems, designed to support laboratories in cancer diagnostics.
Sources: Epredia official site
Epredia scores 54/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Epredia official site
Epredia is a healthcare and manufacturing technology company that produces anatomical pathology equipment used in cancer diagnostics. Founded in 2019 and headquartered in Neuilly-sur-Seine, the company focuses on developing tools and consumables that support laboratories in tissue analysis and diagnostic workflows.
Sources: Epredia official site
Epredia designs and manufactures anatomical pathology equipment and consumables used in cancer diagnostics. Its offerings span the tissue diagnostic workflow, including tissue processing, embedding, slide printing, and identification, intended to help pathology laboratories improve efficiency, workflow, and diagnostic confidence.
Sources: Epredia official site
Epredia can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Epredia official site
Epredia's products are used by pathology laboratories, hospital diagnostic departments, and healthcare professionals involved in cancer diagnostics and tissue analysis.
Sources: Epredia official site
Epredia is known for providing end-to-end anatomical pathology solutions covering tissue processing, embedding, and slide printing and identification, positioning itself as a trusted equipment and consumables provider for pathology laboratories involved in cancer diagnostics.
Sources: Epredia official site
Epredia scores 39/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Epredia has a weak AI-visibility profile at 39/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is trust (55/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #4,209,849 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and a low Moz Domain Authority of 30/100. In a live check, Claude could already identify Epredia from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Epredia: Epoch Elder Care (79/100), Episource (Optum Business) (79/100), ERWEKA (79/100), ESCRS (79/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.